Related Experiment Video

Updated: Mar 22, 2026

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
28:13

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation

Published on: February 26, 2013

34.3K

[Current state of treatment strategies for atrial fibrillation]

C Rogge1, S Hilbert1, N Dagres1

  • 1Abteilung Rhythmologie, Herzzentrum Leipzig, Strümpellstr. 39, 04289, Leipzig, Deutschland.

Herz
|April 13, 2016
PubMed

Insights

Atrial fibrillation (AF), a common heart rhythm disorder, increases stroke and heart failure risks. Research explores new treatments for therapy-resistant AF and maintaining normal heart rhythm to improve patient outcomes.

Area of Science:

  • Cardiology
  • Electrophysiology
  • Internal Medicine

Background:

  • Atrial fibrillation (AF) is the most prevalent persistent cardiac arrhythmia, with rising incidence linked to aging and cardiovascular risk factors.
  • AF significantly impairs quality of life and is associated with high morbidity, including stroke and heart failure.
  • Current therapeutic strategies focus on symptom management and preventing thromboembolic events, heart failure, and comorbidities.

Purpose of the Study:

  • To investigate the electrophysiological mechanisms underlying recurrent, therapy-refractory atrial fibrillation.
  • To determine if maintaining sinus rhythm improves the prognosis for patients with atrial fibrillation.

Main Methods:

  • Pharmacological interventions for heart rate control.
  • Therapeutic strategies for maintaining sinus rhythm, including antiarrhythmic drugs and catheter ablation.
  • Investigating electrophysiological mechanisms of therapy-resistant atrial fibrillation.

Main Results:

  • Complex therapeutic approaches are employed, tailored to individual patient characteristics and symptoms.
  • Treatment options include rate control, rhythm control (antiarrhythmic drugs, catheter ablation).
  • Ongoing research focuses on understanding refractory AF and the prognostic benefits of sinus rhythm maintenance.

Conclusions:

  • Therapy for atrial fibrillation is complex, balancing symptom improvement with complication prevention.
  • Further research is needed to elucidate mechanisms of refractory AF and the impact of sinus rhythm on long-term prognosis.

Keywords:
AnticoagulantsArrhythmogenic substrate analysisCatheter ablationHeart rate and rhythm controlSymptom based management

More Related Videos

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation23:33

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation

Published on: February 28, 2012

84.7K
Robotic Ablation of Atrial Fibrillation11:21

Robotic Ablation of Atrial Fibrillation

Published on: May 29, 2015

20.3K

Related Concept Videos

Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
459
Dysrhythmias VI: Management of Dysrhythmias01:25

Dysrhythmias VI: Management of Dysrhythmias

Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
610
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
431
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
533
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
508
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
573